Assessment of an impact of low-dose or under-dose direct oral anticoagulant on coagulation and fibrinolytic markers in patients with Atrial Fibrillation
Latest Information Update: 30 Nov 2021
At a glance
- Drugs Edoxaban (Primary)
- Indications Thromboembolism
- Focus Pharmacodynamics; Therapeutic Use
- 30 Nov 2021 New trial record